Geron | GERN - Current Liabilities

Stock Price
1.62
Daily Change
0.04 2.53%
Monthly
-10.00%
Yearly
-6.90%
Q1 Forecast
1.53

Geron reported $113.82M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Amgen USD 25.49B 3.7B Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Cassava Sciences USD 48.05M 716K Sep/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Exelixis USD 405.64M 31.86M Dec/2025
Genmab DKK 629M 127M Jun/2025
Geron USD 113.82M 26.11M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Novartis USD 32B 286M Sep/2025
Novavax USD 429.87M 40.73M Sep/2025